Dexrazoxane Intravenous and Trastuzumab and Hyaluronidase
Determining the interaction of Dexrazoxane Intravenous and Trastuzumab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Hyaluronidase and trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Trastuzumab Injection (Intravenous)
- Dexrazoxane Intravenous-Trastuzumab Intravenous
- Dexrazoxane Intravenous-Trastuzumab-anns
- Dexrazoxane Intravenous-Trastuzumab-dkst
- Dexrazoxane Intravenous-Trastuzumab-dkst Intravenous
- Dexrazoxane Intravenous-Trasylol
- Trastuzumab and Hyaluronidase-Dextenza Insert
- Trastuzumab and Hyaluronidase-Dextenza intraocular
- Trastuzumab and Hyaluronidase-Dextran 40
- Trastuzumab and Hyaluronidase-Dextran 70 6% in 5% Dextrose high molecular weight
- Trastuzumab and Hyaluronidase-Dextran 75
- Trastuzumab and Hyaluronidase-Dextran high molecular weight